Endpoints News
Thank you for reading!
basic
UPGRADE
M T Wed Th F
8 December, 2021
Sema4
presented by Catalent
Op­ti­miz­ing Oral Drug De­liv­ery us­ing Zy­dis® Oral­ly Dis­in­te­grat­ing Tablet Tech­nol­o­gy to Ad­dress Pa­tient Chal­lenges
Special
Special report: Meet 20 extraordinary women who are supercharging biopharma R&D
ENDPOINTS NEWS
news
New studies indicate mRNA vaccines provide limited protection against Omicron, but boosters and new shots may be crucial
ENDPOINTS NEWS
Accuser fires back at MIT scientist David Sabatini's claims he was falsely accused of sexual harassment
ENDPOINTS NEWS
Pharma menace Martin Shkreli's old company to pay up to $40M to states for Daraprim price gouging
ENDPOINTS NEWS
Vivo Capital, Bain, Primavera pour $200M into virtually unknown targeted oncology play out of China
ENDPOINTS NEWS
On the heels of Series A, Nomic will join Broad Institute consortium and expand access to platform
ENDPOINTS NEWS
Newpath Partners kicks off $350M fund with a wunderkind holding the bag and an all-star scientific team waiting in the wings
ENDPOINTS NEWS
Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink
STAT
MarketingRx
MarketingRx Matchup: How AbbVie and Biohaven ads rank in head-to-head migraine challenge
ENDPOINTS NEWS
Q&A: Organon chief communications officer Wendy Lund talks about the Merck spinoff, women’s health and why it matters
ENDPOINTS NEWS
MarketingRx roundup: Pfizer re-ups pneumonia ads as Merck threat looms; Real Chemistry founder CEO Jim Weiss steps back
ENDPOINTS NEWS
Webinar: Nonviral production of allogenic CAR-Tscm Cells
In this webinar, learn about Poseida Therapeutics’ approach to transitioning from autologous to fully allogeneic CAR-T therapy manufacturing.
sponsored by Sartorius
in case you missed it
1.
Bioregnum
Premium
'We're in': Roche and Genentech join forces on a multibillion-dollar discovery pact with a brash AI upstart
ENDPOINTS NEWS
2.
AstraZeneca grabs PhIII ATTR drug from Ionis — infusing $200M cash into struggling partner
ENDPOINTS NEWS
3.
Always busy, Gary Glick recruits OrbiMed in a massive $218M Series A for enigmatic data science biotech
ENDPOINTS NEWS
4.
Richard Lerner, antibody pioneer and longtime president of Scripps Research, dies at 83
ENDPOINTS NEWS
5.
Apple Tree Partners leaps across the pond to launch a UK biotech looking to crack the secrets of dendritic cells
ENDPOINTS NEWS
6.
Icelandic billionare's biosimilar company raises $450M, preps for Nasdaq launch with SPAC merger
ENDPOINTS NEWS
7.
London AI-focused BenevolentAI going public in Europe via $438M SPAC deal
ENDPOINTS NEWS
8.
Merck pumps the brakes on two more PhIII trials for its lead anti-HIV drug
ENDPOINTS NEWS
9.
Podcast: Kymera CEO Nello Mainolfi talks targeted protein degradation 
Luke Timmerman
Endpoints Careers
Associate Director/Director, Biostatistics
Astex Pharmaceuticals
Pleasanton, CA, USA
Research Associate - Protein Analytics
Adimab, LLC
Lebanon, NH, USA
Process Development Associate
Aspect Biosystems
Vancouver, BC, Canada
Proposal Manager
MRIGlobal
Gaithersburg, MD, USA
Recruit talent with Endpoints Careers
Contact Melissa Nazzaro: melissa@endpointsnews.com
Endpoints webinars
Dec 08
12:00pm ET
State of the union for advanced medicines
Precision Advance
Dec 09
2:00pm ET
Using external data to accelerate randomized controlled trials without introducing bias
Unlearn
Dec 13
2:30pm ET
Different approaches to process development and manufacturing in gene therapy
3M
Dec 14
12:00pm ET
Checkpoint inhibitors: the gut microbiome’s role in anti-tumor response
TD2
Dec 15
12:00pm ET
Enterprise R&D transformation case study: Genentech
Benchling
Dec 16
12:00pm ET
CQV strategies that increase speed-to-market for gene therapy
Project Farma
Jan 18
11:00am ET
Navigating your biopharma drug candidate through early and mid-stage clinical trials
Catalent
Endpoints at #ASH21
Kyle Blankenship will examine the latest cell and gene therapy R&D news out of ASH21 — sign up today.
sponsored by Endpoints News
Arsalan Arif
.

Once again, congratulations to all 20 extraordinary leaders profiled yesterday at Endpoints' second annual  Women in Biopharma event. We'll have a transcript and recap for premium subscribers available later today, and if you haven't read the special report yet it's open and available for all at this link. Next up on our event calendar is news coverage and analysis from one of the world’s premier cell and gene therapy science conferences, #ASH21 on December 13 — you can sign up here

.
Arsalan Arif
Publisher & Founder, Endpoints News
@AKAarsalan
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Shehla Shakoor
Managing Director
Igor Yavych
Chief Technical Officer
Mike Peck
Chief Revenue Officer
Valentin Manov
Creative Director
Kyle Blankenship
Managing Editor
Amber Tong
Senior Editor
Beth Snyder Bulik
Senior Editor
Zachary Brennan
Senior Editor
Jason Mast
Editor
Nicole DeFeudis
Editor
Max Gelman
Editor
Josh Sullivan
Associate Editor
Kathy Wong
Assistant Editor
Melissa Nazzaro
Sales Director
Cassidy Murphy
Sales Associate
Jaime Bruder
Sr. Operations Manager
Kara Thibault
Operations Manager
Jordan Collins
Operations
Lirra Selibio
Subscriptions
Dawn Cleveland
Controller
Alex Hoffman
Copy Editor
Amanda Florez
Executive Assistant
Alex Lefterov
Graphic Designer
DeAna Catoni
Operations Coordinator
Kari Abitbol
Director, Studio
Julie Notario
Sales Director
Rachel Wilson
Operations Coordinator
Mykola Chornyi
Developer
Derek Graf
Copy/Visuals Editor
Paul Schloesser
Associate Editor
Andriy Tomchyshyn
Lead Developer
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.